Return On Equity of LISATA THERAPEUTICS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
LISATA THERAPEUTICS, INC. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • LISATA THERAPEUTICS, INC. Return On Equity for the quarter ending 30 Sep 2025 was -79%, a 54% decline year-over-year.
  • LISATA THERAPEUTICS, INC. annual Return On Equity for 2024 was -56%, a 46% decline from 2023.
  • LISATA THERAPEUTICS, INC. annual Return On Equity for 2023 was -38%, a 46% increase from 2022.
  • LISATA THERAPEUTICS, INC. annual Return On Equity for 2022 was -70%, a 159% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

LISATA THERAPEUTICS, INC. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -79% -28% -54% 01 Jul 2025 30 Sep 2025
Q2 2025 -70% -23% -50% 01 Apr 2025 30 Jun 2025
Q1 2025 -61% -21% -54% 01 Jan 2025 31 Mar 2025
Q4 2024 -56% -18% -46% 01 Oct 2024 31 Dec 2024
Q3 2024 -51% -15% -42% 01 Jul 2024 30 Sep 2024
Q2 2024 -46% +37% +44% 01 Apr 2024 30 Jun 2024
Q1 2024 -40% +40% +50% 01 Jan 2024 31 Mar 2024
Q4 2023 -38% +32% +46% 01 Oct 2023 31 Dec 2023
Q3 2023 -36% +30% +45% 01 Jul 2023 30 Sep 2023
Q2 2023 -84% -56% -207% 01 Apr 2023 30 Jun 2023
Q1 2023 -80% -55% -224% 01 Jan 2023 31 Mar 2023
Q4 2022 -70% -43% -159% 01 Oct 2022 31 Dec 2022
Q3 2022 -66% -36% -118% 01 Jul 2022 30 Sep 2022
Q2 2022 -27% +7% +21% 01 Apr 2022 30 Jun 2022
Q1 2022 -25% -2% -7.5% 01 Jan 2022 31 Mar 2022
Q4 2021 -27% 0% -0.04% 01 Oct 2021 31 Dec 2021
Q3 2021 -30% -2% -6.9% 01 Jul 2021 30 Sep 2021
Q2 2021 -34% -4% -14% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +59% +72% 01 Jan 2021 31 Mar 2021
Q4 2020 -27% +44% +62% 01 Oct 2020 31 Dec 2020
Q3 2020 -28% 01 Jul 2020 30 Sep 2020
Q2 2020 -30% 01 Apr 2020 30 Jun 2020
Q1 2020 -82% 01 Jan 2020 31 Mar 2020
Q4 2019 -71% 01 Oct 2019 31 Dec 2019
Q4 2015 0% 0% -88% 01 Oct 2015 31 Dec 2015
Q3 2015 0% 0% -11% 01 Jul 2015 30 Sep 2015
Q2 2015 0% 0% -23% 01 Apr 2015 30 Jun 2015
Q1 2015 0% 0% -11% 01 Jan 2015 31 Mar 2015
Q4 2014 0% 0% +10% 01 Oct 2014 31 Dec 2014
Q3 2014 0% +48% 01 Jul 2014 30 Sep 2014
Q2 2014 0% +64% 01 Apr 2014 30 Jun 2014
Q1 2014 0% +106% 01 Jan 2014 31 Mar 2014
Q4 2013 0% +98% +100% 01 Oct 2013 31 Dec 2013
Q3 2013 -48%* +38% 01 Jul 2013 30 Sep 2013
Q2 2013 -64%* +7% 01 Apr 2013 30 Jun 2013
Q1 2013 -106%* -54% 01 Jan 2013 31 Mar 2013
Q4 2012 -98% 01 Oct 2012 31 Dec 2012
Q3 2012 -86% 01 Jul 2012 30 Sep 2012
Q2 2012 -72% 01 Apr 2012 30 Jun 2012
Q1 2012 -53% 01 Jan 2012 31 Mar 2012

LISATA THERAPEUTICS, INC. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -56% -18% -46% 01 Jan 2024 31 Dec 2024
2023 -38% +32% +46% 01 Jan 2023 31 Dec 2023
2022 -70% -43% -159% 01 Jan 2022 31 Dec 2022
2021 -27% 0% -0.04% 01 Jan 2021 31 Dec 2021
2020 -27% +44% +62% 01 Jan 2020 31 Dec 2020
2019 -71% -32% -83% 01 Jan 2019 31 Dec 2019
2018 -39% -98% -165% 01 Jan 2018 31 Dec 2018
2017 59% +457% 01 Jan 2017 31 Dec 2017
2016 -397% 01 Jan 2016 31 Dec 2016
2014 -91% +7% +7.1% 01 Jan 2014 31 Dec 2014
2013 -98% 0% -0.29% 01 Jan 2013 31 Dec 2013
2012 -98% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.